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Correlation between symptoms developed after the oral ingestion
of 50 g lactose and results of hydrogen breath testing for lactose
intolerance
Abstract
BACKGROUND: Lactase deficiency is a common condition responsible for various abdominal
symptoms. Lactose hydrogen breath test is currently the gold standard in diagnosing lactose intolerance.
AIM: To assess sensitivity and specificity of symptoms developed after oral lactose challenge.
METHODS: Intensity of nausea, abdominal pain, borborygmi, bloating and diarrhoea was recorded
every 15 min up to 3 h after ingestion of 50 g lactose in patients with positive (i.e. breath
H2-concentration > or =20 p.p.m. above baseline) and negative lactose hydrogen breath test. RESULTS:
Between July 1999 and December 2005, 1127 patients (72% females) underwent lactose hydrogen
breath test. A positive result was found in 376 (33%). Sensitivity of individual symptoms ranged from
39% (diarrhoea) to 70% (bloating) while specificity ranged from 69% (bloating) to 90% (diarrhoea). A
positive lactose hydrogen breath test was found in 21% of patients with one symptom, 40% of patients
with two symptoms, 44% of patients with three symptoms, 67% of patients with four symptoms and
82% of patients with five symptoms. Symptom intensity was significantly higher for each symptom in
the positive group. CONCLUSION: Evaluating symptoms developed after ingestion of 50 g lactose can
be used as a simple screening test to select patients who need to be referred for lactose intolerance
testing.
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Abstract (Word count 197) 
 
Background: Lactase deficiency is a common condition responsible for various 
abdominal symptoms. Lactose hydrogen breath test (H2-BT) is currently the gold 
standard in diagnosing lactose intolerance.  
 
Aim: Assessing sensitivity and specificity of symptoms developed after oral lactose 
challenge. 
 
Methods: Intensity of nausea, abdominal pain, borborygmi, bloating and diarrhea was 
recorded every 15 minutes up to 3 hours after ingestion of 50g lactose in patients 
with positive (i.e.  breath H2-concentration ≥20 ppm above baseline) and negative 
lactose H2-BT. 
 
Results: Between July 1999 and December 2005 1127 patients (72% females) 
underwent lactose H2-BT A positive result was found in 376 (33%). Sensitivity of 
individual symptoms ranged from 39% (diarrhea) to 71% (bloating) while specificity 
ranged from 69% (bloating) and 90% (diarrhea). A positive H2-BT was found in 21% 
of patients with one symptom, 40% of patients with 2 symptoms, 44% of patients with 
3 symptoms, 67% of patients with 4 symptoms and 82% of patients with 5 symptoms. 
Symptom intensity was significantly higher for each symptom in the positive group. 
 
Conclusion: Evaluating symptoms developed after ingestion of 50g lactose can be 
used as a simple screening test to select patients that need to be referred for lactose 
intolerance testing. 
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Introduction 
 
Lactose intolerance is a common condition affecting a large proportion of the world’s 
population1. The prevalence of lactose intolerance differs in various parts of the world 
ranging from 3-8% in the Scandinavian and Northwest Europe population to 50-100% 
of the Southeast Asian population2,3,4. In Europe the prevalence increases towards 
South and East reaching 70% in southern Italy and Turkey5. The most common 
cause of lactose intolerance is lactase deficiency - a decreased production of the 
enzyme lactase in the small intestinal villi. Lactase deficient individuals are not able 
to cleave this disaccharide in glucose and galactose and may become symptomatic 
after the ingestion of lactose.  As a consequence, lactose reaches the large intestine 
where it is metabolized by the colonic flora. The high osmotic load caused by lactose 
in the small intestine and the bacterial metabolites are considered to play an 
important role in the genesis of the classic symptoms of lactose intolerance such as 
diarrhea, bloating, nausea, borborygmi and abdominal pain. 
 
Lactose hydrogen breath test (H2-BT) has been used for more than 30 years to 
diagnose lactase deficiency in clinical practice 6. This test exploits the fact that normal 
colonic flora metabolizes lactose into hydrogen (H2) and short chain fatty acids. 
Hydrogen reaches the splanchnic venous circulation by diffusion through the 
intestinal wall, is transported from here through the portal system to the liver and the 
systemic circulation and is eventually exhaled through the lungs. The sensitivity and 
specificity of an increase in H2 concentration in the exhaled air to diagnose lactose 
intolerance range from 76-94% and 77-96%, respectively7. While the H2-BT is 
considered the “gold standard” of the non-invasive tests to diagnose lactose 
intolerance there is limited information on the sensitivity and specificity of symptoms 
developed in response to the ingestion of a given amount of lactose8. 
 
The aim of this study was to evaluate the sensitivity and specificity of symptoms 
developed after the ingestion of 50g of lactose for a positive H2-BT. We hypothesized 
an association between the number of symptoms developed after the ingestion of 
50g of lactose and a positive hydrogen breath test.  
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Materials and methods 
 
Data from all patients referred for H2-BT between 1999 and 2005 were collected 
prospectively. Demographic data included age, gender and country of origin (grouped 
by “Swiss” vs. “non-Swiss”). They included both the result of the test itself and 
information on symptom occurrence and severity after lactose ingestion as recorded 
in a structured questionnaire. 
 
Breath H2 concentration was measured using a H2 breath test device (Stimotron 
Medizinische Geräte GmbH, Wendelstein, Germany) equipped with an 
electrochemically working hydrogen cell. The breath analyser is able to detect H2 
concentrations in the range of 0-250 parts per million (ppm) with an accuracy of ± 2% 
(1ppm at values below 50ppm). The instrument was calibrated using standardized 
compressed gas with a H2 concentration of 96.8 ppm (Calibration Gas, compressed 
gas, No. 5, BDL. A/R). Air samples (20 ml each) were insufflated in the H2 breath test 
device and the H2 concentration was read from a digital panel meter. 
 
Patients underwent the H2-BT after fasting overnight at the Gastrointestinal Function 
Unit of the University Hospital of Zurich Patients were asked to be fasting and refrain 
from smoking for at least 6 hours prior to the test. Furthermore patients were asked 
to discontinue possible use of antibiotics one week and laxatives one day before the 
H2BT. Prior to the beginning of the test, two samples of mixed end-expired air were 
aspirated into a 20ml plastic syringe (Injekt 20ml, Braun) fitted with a three-way 
stopcock. The sample with the higher amount of H2 was used as baseline value and 
the test was performed provided both values were below 20ppm. After determining 
the baseline H2 breath concentration, the subject ingested 50g of lactose dissolved in 
300ml of water. Over a 2-3 hour period breath samples were collected as described 
above at 15 minutes intervals while the patient was in sitting position. At the time of 
breath sampling patients were asked to rate 5 symptoms (abdominal pain, nausea, 
bloating, borborygmi and diarrhea) using a 9-point scale (0 – no symptom to 9 – 
worst symptom severity). 
 
Gelöscht: on 
Gelöscht: who underwent
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For each patient we determined the maximal intensity of each of the 5 symptoms as 
the highest symptom intensity value recorded during the duration of the breath test 
 
The lactose H2-BT was considered positive if the H2 concentration in the exhaled air 
exceeded 20 ppm above baseline at least twice during the monitoring period9. A 
symptom was considered positive if the patient reported a 2-point or more increase 
above baseline in the severity of the symptom at least twice. 
 
The data analysis was approved by the ethical committee of the University Hospital 
of Zurich and of the Canton of Zurich, Switzerland.  
 
Statistical analysis 
 
The Chi-square test was utilized to analyze differences between proportions. 
Differences in the mean age of patients with positive and negative breath test were 
compared by using the unpaired Student t-test. Correlations between variables were 
quantified by calculating the Spearman-rank correlation coefficients. The significance 
level of all statistical analyses was set at alpha=0.05.  
 
Results 
 
Between July 1999 and December 2005, 1127 patients underwent a H2-lactose 
breath test. Their mean age was 39.8 years (range 7-87), 71.6% were women 
(n=807) and 28.4% men (n=320). Three hundred seventy-six (33.4%) patients had a 
positive H2-lactose breath test indicative of lactase deficiency. The mean age of 
patients with a positive (mean ± SD: 39.6 ± 15.6 years) and negative test (40.2 ± 15.3 
years) did not differ significantly (p=0.51). Similarly, no statistically significant 
association was found between gender and the result of the H2-lactose breath test 
(p=0.086). Swiss patients were less likely (p<0.001) to have a positive H2-lactose 
breath test result (169/746; 22.7%) compared to non-Swiss individuals (207/381; 
54.3%). 
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Sensitivity and specificity of individual symptoms 
 
After the ingestion of 50g lactose, 370 (32.8%) patients reported nausea, 495 
(43.9%) bloating, 220 (19.5%) diarrhea, 432 (38.3%) borborygmi and 419 (37.2%) 
abdominal pain. Bloating was the most sensitive (71%) and diarrhea the most 
specific (90%) symptom. At the present test positivity of 33.4%, diarrhea had the 
highest positive predictive value (66%) and bloating the highest negative predictive 
value (82%). The sensitivity, specificity and predictive values of the individual 
symptoms are presented in table 1. The table also lists the likelihood ratios for the 
different symptoms as this figure, contrary to predictive values, is independent of pre-
test probability, i.e. disease prevalence.  
 
Sensitivity and specificity of combinations of symptoms 
 
Three hundred twenty six (28.9%) patients did not develop any symptoms during the 
monitoring period. In this group of patients, 288 (88%) had a negative H2-lactose 
breath test. The proportion of patients with a positive H2-lactose breath test 
increased with the number of symptoms developed after the ingestion of 50g lactose 
from 21% in those developing only one symptom to 82% in those developing all 5 
symptoms (Figure 1a). There was a strong positive correlation between the number 
of symptoms and percentage of patients with a positive H2-lactose breath test 
(r=0.989; p<0.001).  
Only a small proportion (20/241; 8.2%) of Swiss patients reporting no symptoms had 
a positive H2-breath test result whereas 31.8% (7/22) had a negative test despite 5 
symptoms were present. Among non-Swiss, a larger proportion with no symptoms 
(18/85=21.2%) and of those reporting all 5 symptoms (31/34; 91.2%) had a positive 
H2-breath test result. The proportion of Swiss and non-Swiss patients with a positive 
H2-lactose breath test depending on the number of symptoms reported during the 
test are shown in figures 1b and 1c respectively. Sensitivity, specificity, PPV, NPV, 
positive and negative likelihood ratios of one, two, three, four and five symptoms to 
identify a positive lactose H2 breath test are detailed in table 2. 
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Intensity of symptoms in patients with positive vs. negative breath tests 
 
Patients with a positive H2-lactose breath test reported higher symptom intensities 
compared to patients with a negative breath test. The differences in symptom 
intensity (Figure 2) were statistically significant for all 5 symptoms: abdominal pain 
(3.5 ± 0.1 vs. 2.1 ± 0.1; p<0.05), nausea (2.7 ± 0.1 vs 2.1± 0.1; p<0.05), bloating (4.3 
± 0.1 vs. 2.6 ± 0.1; p<0.05), diarrhea (2.6 ± 0.2 vs. 0.8 ± 0.1; p<0.05) and borborygmi 
(3.7 ± 0.1 vs. 1.8 ± 0.1; p<0.05). These differences were significantly different even 
when Swiss and Non-Swiss patients were analyzed separately. 
 
 
Discussion 
 
In the present study, we report the sensitivity and specificity of abdominal pain, 
nausea, bloating, borborygmi and diarrhea developed in response to the ingestion of 
50g lactose to identify patients with lactase deficiency as shown by a positive H2-BT. 
This information is important since symptoms of lactose intolerance overlap with 
features of irritable bowel syndrome and, thus, discrimination between these two 
disease entities may result difficult10. We found that bloating had the best sensitivity 
(71%) and negative predictive value (82%) while diarrhea had the best specificity 
(90%) and positive predictive value (66%) to identify patients with a positive H2-BT. 
Twenty-one percent of patients who developed one symptom after the ingestion of 
50g lactose were found to have lactase deficiency based on the results of the lactose 
H2-BT. Eighty-one percent of patients who developed all 5 symptoms had a positive 
(abnormal) lactose H2-BT. These data indicate that evaluation of symptoms 
developed in response to the ingestion of a predefined amount of lactose could 
represent a simple screening test for lactose intolerance. 
 
In a pragmatic approach we consider that patients who do not develop any symptoms 
after ingesting 50 grams of lactose do not need to be referred for hydrogen breath 
testing as (1) the likelihood of the test being positive is around 10% and (2) even in 
the case of a positive result it would be difficult to justify the clinical benefits of a 
lactose free diet in the absence of symptoms. At the other end of the spectrum, one 
might argue that a hydrogen breath testing would not be necessary in patients who Gelöscht: will 
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develop all 5 symptoms as the likelihood of them having a positive test is high (68-
91% depending on demographic background). Recommending these patients to 
strictly adhere to a lactose-free diet and reevaluate of their symptom pattern after 4 - 
6 weeks could be tried first. As lactose is used in various processed foods a 
consultation with a dietician might be necessary in some patients to ensure 
adherence to a lactose-free diet. Patients with persisting symptoms on a lactose free 
diet should be examined for other pathologies. In patients improving on a lactose-free 
diet formal documentation of low lactase activity would be required given the major 
lifestyle and diet changes implied by a life-long diagnosis of lactose intolerance. 
 
Lactose intolerance testing should be recommended to patients who develop two or 
three symptoms after the ingestion of 50g lactose as the pretest probability of them 
having a positive or negative test is in the range of a coin toss. The same applies for 
patients who develop one or four symptoms after the ingestion of 50g lactose. 
Although patients developing one symptom are more likely to be negative and 
patients developing 4 symptoms are more likely to be positive, testing should be 
performed as this may have implications on lifestyle and diet. An important 
discussion point would be whether to perform a hydrogen breath test or a LCT gene 
test. Enattah et al reported adult-type hypolactasia in patients homozygote C/C to the 
C/T-13910 variant and in patients homozyote G/G to the G/A-22018 variant11. Testing 
the single nucleotid polymorphism of the C/T-13910 base pair on the short arm of 
chromosome 2q.21-22 is commercially available in certain laboratories. In a recent 
study Högenauer et al documented an excellent agreement between CC genotype 
and positive H2-breath test (36/37 patients with CC genotype had a positive lactose 
H2-breath test)12. Therefore, if available, genetic testing (LCT 13910 test) in patients 
with symptoms developed after the ingestion of 50g lactose might be used instead of 
a standard lactose H2 breath test. 
 
Data in Swiss vs. non-Swiss patients indicate that the utility of the clinical test 
depends on the prevalence of lactose intolerance in a given population. With overall 
22.7% positive breath test results the Swiss population can be regarded as a 
population group with relative low prevalence of lactose intolerance. Conversely the 
group of non-Swiss patients with overall 54.3% positive breath test results can be 
considered as a population group with medium high prevalence of lactose 
Gelöscht: about 80%
Gelöscht: In 
Gelöscht: we would 
recommend
Gelöscht: ing
Gelöscht: ion
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intolerance. The relationship between H2-breath test result and number of symptoms 
during the test in Swiss and non-Swiss patients indicate that clinical utility of the 
symptom analysis in response to the ingestion of 50g lactose is even higher when the 
prevalence of lactose intolerance in a tested population is known. By using the 
likelihood ratios, post-test probabilities, i.e. the probability that the H2-BT is positive 
or negative in presence or absence of symptoms, respectively, can be easily 
calculated for populations with different prevalence of lactose intolerance. 
 
An additional rationale for a focused selection of patients referred for lactose 
intolerance testing is resource utilization. Although the lactose H2 breath test is not 
invasive and its direct costs are low, its performance requires a dedicated health-care 
person to collect breath samples over a period of 3-4 hours. From the patient 
perspective, the test is associated with a half to one day of missed work. Filling out 
only a symptom diary following the ingestion of 50g lactose offers the patient 
flexibility with regard to timing and place where to perform the test. Genetic testing 
involves a “simple blood draw” but the price of this test is high and not readily 
available everywere. Using the symptom response to lactose challenge as an initial 
test would allow screening out patients who don’t develop symptoms (20-30% of 
patients referred for testing). 
 
There are only few recent studies evaluating the relationship between symptoms and 
the result of the H2-BT. Hermans et al. evaluated the severity of bloating, flatulence, 
abdominal distension and diarrhea in 309 consecutive patients referred for lactose 
H2-BT as part of the work-up of unexplained abdominal complaints13. Patients were 
asked to score their symptoms semi-quantitatively as 0 (no complaint), 1 (moderate 
complaint) or 2 (severe complaint). The total symptom score (TSS) was computed as 
the sum of these symptoms. In this group of patients, they noticed an abnormal H2-
BT (i.e. raise of exhaled H2 concentration >20 ppm above baseline following the 
ingestion of 50g lactose) in 39.5% of patients. The mean TSS of patients with a 
positive H2-BT (TSS = 1.65) was significantly (p<0.001) higher than the mean score 
of patients with a negative H2-BT (TSS = 0.96). In addition, the authors noted that the 
peak H2-excretion was higher in patients with higher TSS compared to those with low 
TSS. Based on these data the authors concluded that gastrointestinal symptoms 
after 50g lactose challenge are strongly associated with the amount of breath H2 
Gelöscht: ¶
Hydrogen breath testing should 
be recommended to patients 
who develop two or three 
symptoms after the ingestion of 
50g lactose as the pretest 
probability of them having a 
positive or negative test is in the 
range of a coin toss. The 
challenging groups of patients 
are those developing one or four 
symptoms after the ingestion of 
50g lactose. In these patients 
our current recommendation is 
that the decision of testing or 
empirically treating should be left 
at the discretion of the patient 
and his or her physician. Cost-
effectiveness analysis and 
decision modeling could provide 
additional information in favor or 
against these recommendations 
and help in defining the 
management of patients 
suffering one or 4 symptoms 
after the lactose ingestion test.¶
Gelöscht:  
Gelöscht: lactose H2-BT  
Gelöscht:  for this test.
Gelöscht: that 
Gelöscht: ts
Gelöscht: the 
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excretion. Unfortunately the authors did not provide an additional analysis of 
individual symptoms. 
Suarez et al performed a randomized, double-blind, controlled study comparing 
symptoms in 30 patients with self-reported severe lactose intolerance14. Each patient 
received 240ml of either 2% fat milk containing on average 12.1g lactose or 2% fat 
lactose-hydrolyzed milk for breakfast over a 2 week period and was asked to rate the 
occurrence and severity of bloating, abdominal pain / cramps and rectal gas 
distension during the 24-h period after each meal. The severity of symptoms was 
assessed on a 6-point scale (0-no symptoms, 1-trivial symptoms and up to 5-severe 
symptoms). Twenty-one (70%) patients were considered to have lactose 
malabsorbtion based on the results of lactose H2-BT (i.e. exhaled H2 concentration 
raise >10ppm following the ingestion of 15g lactose) while the others were classified 
as lactose-absorbers. Reviewing the diaries of these patients the authors noticed no 
difference in the severity of symptoms when patients consumed regular milk and 
lactose-hydrolyzed milk and no difference between the lactose-absorber and lactose-
malabsorber group. Furthermore, although patients believed they were severely 
lactose intolerant the mean symptom scores recorded in their diaries were in trivial – 
mild range. These data suggest that even patients who consider themselves severely 
lactose intolerant can tolerate up to one glass (240ml) of milk a day. 
 
The current study has some limitations. The positive and negative predictive values 
for individual symptoms and their combination depend on the prevalence of lactase 
deficiency in the examined population. Thus, these values should be interpreted with 
caution outside Central Europe. Nevertheless, in our study we calculated the 
respective likelihood ratio that allow to apply results to different prevalence scenarios. 
Although data were collected prospectively, we do not have clinical follow-up data to 
test the appropriateness of the proposed approach for patients who developed 
symptoms after the ingestion of lactose intolerance. A prospective trial to evaluate 
the validity and acceptance of the clinical lactose challenge needs to be performed. 
Last but not least, since patients included in the present study were patients referred 
for H2 breath testing, a certain selection bias might be present. Thus, caution is 
advised when extrapolating present data to the general population but data would be 
applicable for patients suspected of having lactose intolerance. 
 
Gelöscht: In addition, cost-
effectiveness analysis is required 
to estimate the benefit of our 
recommended approach.
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In conclusion, the results of the present study offer the basis for developing a simple 
clinical lactose tolerance test aimed at screening patients who require further testing 
for hypolactasia. Gelöscht: lactose intolerance
  Beyerlein 12 
 
 
Study highlights: 
- Lactose intolerance is a prevalent condition causing diarrhea, bloating, 
nausea, borborygmi and abdominal pain 
- The present study reports the sensitivity, specificity, PPV, NPV, pos. LR 
and neg. LR of each symptom developed after the ingestion of 50g lactose 
to identify patients with lactose intolerance 
- The likelihood of an abnormal lactose hydrogen breath test increases 
parallel to the number of symptoms developed after the ingestion of 50g 
lactose 
- Clinical evaluation of symptoms developed after the ingestion of 50g 
lactose could be used to screen patient who require further testing for 
lactose intolerance 
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Table 1: Sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV), positive (LR+) and negative (LR-) likelihood ratios of 
individual symptoms in 1127 patients  
 
Total 
n=1127 Sensitivity Specificity PPV NPV LR+ LR- 
Nausea 41% 71% 41% 71% 1.4 0.8 
Bloating 71% 69% 54% 82% 2.3 0.4 
Diarrhea 39% 90% 66% 75% 3.9 0.7 
Borborygmi 65% 75% 56% 81% 2.6 0.4 
Abdominal pain 55% 72% 49% 76% 2.0 0.6 
 
Swiss 
n=746 Sensitivity Specificity PPV NPV LR+ LR- 
Nausea 39% 72% 28% 80% 1.4 0.8 
Bloating 71% 69% 40% 89% 2.3 0.4 
Diarrhea 31% 91% 50% 82% 3.4 0.8 
Borborygmi 60% 76% 42% 87% 2.5 0.5 
Abdominal pain 51% 71% 34% 83% 1.8 0.7 
 
Non-Swiss 
n=381 Sensitivity Specificity PPV NPV LR+ LR- 
Nausea 42% 69% 62% 50% 1.4 0.8 
Bloating 70% 72% 75% 67% 2.5 0.4 
Diarrhea 45% 87% 80% 57% 3.5 0.6 
Borborygmi 69% 71% 74% 66% 2.4 0.4 
Abdominal pain 58% 74% 72% 59% 2.2 0.6 
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Table 2: Sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV), positive (LR+) and negative (LR-) likelihood ratios of 1, 2, 3, 4 
and 5 symptoms developed after oral ingestion of 50 g lactose. Patients developing 
no symptoms (38 positive H2BT and 288 negative H2BT) were used as reference.  
 
Total (N=1127) 
 Sensitivity Specificity PPV NPV LR+ LR- 
1 symptom (N=257) 58% 59% 21% 88% 1.4 0.7 
2 symptoms (N=202) 68% 70% 40% 88% 2.3 0.5 
3 symptoms (N=149) 63% 78% 44% 88% 2.8 0.5 
4 symptoms (N=137) 71% 86% 67% 88% 5.2 0.3 
5 symptoms (N=56) 55% 97% 82% 88% 16.3 0.5 
 
Swiss (N=746) 
 Sensitivity Specificity PPV NPV LR+ LR- 
1 symptom (N=184) 53% 58% 13% 92% 1.3 0.8 
2 symptoms (N=136) 70% 71% 34% 92% 2.4 0.4 
3 symptoms (N=90) 57% 78% 29% 92% 2.5 0.6 
4 symptoms (N=73) 66% 87% 53% 92% 5.0 0.4 
5 symptoms (N=34) 43% 97% 68% 92% 14.0 0.6 
 
Non-Swiss (N=381) 
 Sensitivity Specificity PPV NPV LR+ LR- 
1 symptom (N=73) 63% 61% 41% 79% 1.6 0.6 
2 symptoms (N=66) 66% 68% 53% 79% 2.1 0.5 
3 symptoms (N=59) 69% 78% 68% 79% 3.1 0.4 
4 symptoms (N=64) 75% 86% 83% 79% 5.3 0.3 
5 symptoms (N=34) 63% 96% 91% 79% 14.8 0.4 
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Figure 1: Number (values on the chart) and percentage (Y-axis) of patients with 
positive and negative breath tests based on the number of symptoms developed after 
the ingestion of 50g lactose in all patients (a), Swiss (b) and non-Swiss (c) subgroup.  
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Figure 2: Comparison of the mean maximal symptom intensity in patients with a 
positive and a negative hydrogen breath test. Patients with a positive H2-lactose 
breath test reported more intense symptoms compared to their lactose H2-breath test 
negative counterparts. 
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